Literature DB >> 25769715

Role for radiation therapy in melanoma.

Wenyin Shi1.   

Abstract

Although melanoma is generally considered a relative radioresistant tumor, radiation therapy (RT) remains a valid and effective treatment option in definitive, adjuvant, and palliative settings. Definitive RT is generally only used in inoperable patients. Despite a high-quality clinical trial showing adjuvant RT following lymphadenectomy in node-positive melanoma patients prevents local and regional recurrence, the role of adjuvant RT in the treatment of melanoma remains controversial and is underused. RT is highly effective in providing symptom palliation for metastatic melanoma. RT combined with new systemic options, such as immunotherapy, holds promise and is being actively evaluated.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Melanoma; Radiation treatment; Stereotactic body radiation treatment (SBRT); Stereotactic radiosurgery (SRS)

Mesh:

Year:  2015        PMID: 25769715     DOI: 10.1016/j.soc.2014.12.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  6 in total

1.  Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.

Authors:  R R Maniyar; S Chakraborty; T Jarboe; R Suriano; M Wallack; J Geliebter; R K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions.

Authors:  Rachel A Fayne; Francisco I Macedo; Steven E Rodgers; Mecker G Möller
Journal:  Oncol Rev       Date:  2019-11-28

3.  The value of melanoma inhibitory activity and LDH with melanoma patients in a Chinese population.

Authors:  Chujun Li; Jinfang Liu; Lu Jiang; Jun Xu; Anjing Ren; Yu Lin; Gang Yao
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

4.  Association between excision margins and local recurrence in 1407 patients with primary in situ melanomas.

Authors:  Licata Gaetano; Birra Domenico; Serigne N Lo; Tasnia Hamed; Alison J Potter; John F Thompson; Richard A Scolyer; Pascale Guitera
Journal:  JAAD Int       Date:  2022-06-16

5.  Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers.

Authors:  Yuki Katoh; Hiroyuki Hara; Tomonori Harada; Shuichi Hirai
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

6.  A melanotic malignant melanoma presenting as a keloid: A case report.

Authors:  Jinjing Jia; Min Wang; Liumei Song; Yiguo Feng
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.